2nd IPF Summit 2018


The 2nd IPF Summit is the IPF industry definitive discussion and networking forum, helping drug developers to solve the translational gap between limited preclinical predictability and corresponding clinical attrition.

Built with Boehringer Ingelheim, Bristol Myers Squibb and Celgene, this intimate summit will pre-competitively advance the field beyond empirical data and more confidently translate IPF candidates through drug development pipelines.

Exhibitors

Gerald Nabozny (Boehringer Ingelheim), Joe Arron (Genentech), Fernando Martinez (Weill Cornell Medical College), Timothy Blackwell (Vanderbilt University Medical Center), Jan De Backer (FLUIDDA)

Go to event website